UBS Group’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-107,102
Closed -$18.4M 9958
2021
Q3
$18.4M Buy
107,102
+30,818
+40% +$5.3M 0.01% 1162
2021
Q2
$9.57M Sell
76,284
-9,088
-11% -$1.14M ﹤0.01% 1544
2021
Q1
$11.6M Sell
85,372
-2,415
-3% -$328K ﹤0.01% 1353
2020
Q4
$11.2M Buy
87,787
+2,847
+3% +$364K ﹤0.01% 1326
2020
Q3
$9.56M Sell
84,940
-9,051
-10% -$1.02M ﹤0.01% 1309
2020
Q2
$8.96M Sell
93,991
-44,282
-32% -$4.22M ﹤0.01% 1250
2020
Q1
$12.4M Sell
138,273
-63,486
-31% -$5.71M 0.01% 988
2019
Q4
$10.7M Sell
201,759
-34,985
-15% -$1.85M ﹤0.01% 1455
2019
Q3
$9.35M Buy
236,744
+53,897
+29% +$2.13M ﹤0.01% 1419
2019
Q2
$7.51M Buy
182,847
+24,374
+15% +$1M ﹤0.01% 1550
2019
Q1
$7.38M Sell
158,473
-108,102
-41% -$5.03M ﹤0.01% 1534
2018
Q4
$11.6M Buy
266,575
+69,387
+35% +$3.02M 0.01% 1135
2018
Q3
$11.3M Buy
197,188
+4,775
+2% +$273K ﹤0.01% 1325
2018
Q2
$9.34M Sell
192,413
-87,470
-31% -$4.24M ﹤0.01% 1446
2018
Q1
$10.9M Buy
279,883
+121,682
+77% +$4.76M ﹤0.01% 1271
2017
Q4
$6.71M Sell
158,201
-2,629
-2% -$112K ﹤0.01% 1615
2017
Q3
$6M Buy
160,830
+54,780
+52% +$2.04M ﹤0.01% 1617
2017
Q2
$3.22M Buy
106,050
+56,927
+116% +$1.73M ﹤0.01% 2024
2017
Q1
$1.3M Sell
49,123
-7,967
-14% -$211K ﹤0.01% 2664
2016
Q4
$1.46M Buy
57,090
+20,579
+56% +$525K ﹤0.01% 2525
2016
Q3
$1.32M Sell
36,511
-5,464
-13% -$198K ﹤0.01% 2558
2016
Q2
$1.43M Buy
41,975
+4,274
+11% +$145K ﹤0.01% 2445
2016
Q1
$995K Sell
37,701
-5,528
-13% -$146K ﹤0.01% 2662
2015
Q4
$2.11M Buy
43,229
+7,212
+20% +$352K ﹤0.01% 2148
2015
Q3
$897K Buy
36,017
+35,217
+4,402% +$877K ﹤0.01% 2725
2015
Q2
$25K Sell
800
-253
-24% -$7.91K ﹤0.01% 5335
2015
Q1
$40K Buy
+1,053
New +$40K ﹤0.01% 4838